Plasma titration provides a physical ruler for cross-platform proteomics
Liu, Y.; Wang, H.; Zhang, Y.; Lu, R.; Xu, W.; Hou, W.; Zhu, Y.; Li, X.; Chen, Q.; Gao, Y.; Zhang, S.; Chen, Q.; An, Z.; Yu, J.; Ying, W.; Yu, X.; Wu, J.; Fan, Z.; Yao, X.; Li, Z.; Shan, H.; Guo, T.; Ye, Z.; Yu, X.; Liu, G.; Yu, Y.; Peng, Z.; Ding, C.; Tian, Q.; Zhang, R.; Li, J.; Fang, X.; He, F.; Jin, L.; Chen, X.; Shi, L.; Zheng, Y.
Show abstract
Plasma proteomics is expanding across platforms and cohorts, and integrating these data for AI demands comparability at the protein level, not merely concordant associations1,2. Affinity and MS platforms use distinct probes (antibodies, aptamers, or peptides) and signal readouts, yielding contradictory cross-platform results3,4. Without a known quantitative truth, we cannot distinguish biology from measurement distortion, leaving no gold standard for integration. Here we introduce Plasmix--a plasma reference suite with predefined male:female ratios (M, 1:0; Y, 3:1; P, 1:1; X, 1:3; F, 0:1)--and show that preserving this quantitative titration gradient, not just technical repeatability, predicts cross-platform concordance and identifies protein measurements suitable for integration. Profiling Plasmix across five platforms (Olink, SomaScan, NULISA, AAgAtlas, and MS-DIA) and 12 protocols across 17 batches, we found discordance is dominated by signal generation, not sample identity, and platforms distort signals in a protein-specific manner. Crucially, proteins retaining the titration response showed stronger agreement in an independent cohort; anchoring to the Plasmix midpoint (P) via sample-to-reference ratios reduced distortions, extending harmonizable coverage by 10-20%. Plasmix thus provides a physical ruler to benchmark accuracy, identifying genuinely integrable measurements before pooling datasets or training AI models--a critical bottleneck for plasma proteomics.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Minimal Correlation but Complementary Diagnostic Utility for Plasma Cell-free RNA and Proteins 91%
- Deep Proteome Profiling of Metabolic Dysfunction-Associated Steatotic Liver Disease 90%
- The Interpretable Multimodal Machine Learning (IMML) framework reveals pathological signatures of distal sensorimotor polyneuropathy 88%
Similar papers in this journal
- Deep learning-based event classification of mass photometry data for optimal mass measurement at the single-molecule level 92%
- Chromato-kinetic fingerprinting enables multiomic digital counting of single disease biomarker molecules 90%
- Quantum Dot Encoding for In-Solution Single-Molecule Biomarker Counting in Metastatic Prostate Cancer 89%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.